Achieve Life Sciences, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
Achieve Life Sciences, Inc. (ACHV) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $906.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2025-03-11
- Achieve Life Sciences, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2024 was $906.00K, a 89.94% increase from fiscal 2023.
- Achieve Life Sciences, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2023 was $477.00K, a 59.53% increase from fiscal 2022.
- Achieve Life Sciences, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was $299.00K, a 33.48% increase from fiscal 2021.
- Achieve Life Sciences, Inc. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was $224.00K, a 89.83% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $906.00K 10-K · filed 2025-03-11 | |
| 2023-12-31 | $477.00K 10-K · filed 2025-03-11 | |
| 2022-12-31 | $299.00K 10-K · filed 2025-03-11 | |
| 2021-12-31 | $224.00K 10-K · filed 2024-03-28 | |
| 2020-12-31 | $118.00K 10-K · filed 2023-03-16 | |
| 2019-12-31 | $116.00K 10-K · filed 2022-03-10 | |
| 2018-12-31 | $70.00K 10-K · filed 2021-03-11 | |
| 2017-12-31 | -$174.00K 10-K · filed 2020-03-13 | |
| 2016-12-31 | $67.00K 10-K · filed 2017-02-23 | |
| 2015-12-31 | $14.00K 10-K · filed 2017-02-23 | |
| 2014-12-31 | $452.00K 10-K · filed 2017-02-23 | -$452.00K 10-K · filed 2015-03-26 |
| 2013-12-31 | $738.00K 10-K · filed 2016-03-09 | -$738.00K 10-K · filed 2014-03-11 |
| 2012-12-31 | -$1.21M 10-K · filed 2015-03-26 | |
| 2011-12-31 | -$2.37M 10-K · filed 2014-03-11 | |
| 2010-12-31 | $425.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |